Learn what zavegepant is, how this next-generation CGRP receptor antagonist works, and why its fast-acting nasal spray formulation is a game-changer for acute migraine treatment, especially for patients with nausea or vomiting.
Learn what zavegepant is, how this intranasal CGRP receptor antagonist works for acute migraine treatment, and why its non‑vasoconstrictive, needle‑free nasal spray delivery may benefit patients with nausea or cardiovascular risk factors.
Learn what atogepant is, how this next-generation oral CGRP receptor antagonist works for migraine prevention, and key clinical trial results on efficacy, onset of action, and safety.